PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Norgestrel→

Norgestrel PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
6533-00-2
Molecular formula
C21H28O2
Molecular weight
312.4 g/mol
Drug class
Synthetic progestogensteroidal progestin used in hormonal contraception
Mechanism of action
Activates progesterone receptors and, in combined oral contraceptives, suppresses ovulation. Additional contraceptive actions include thickening cervical mucus and producing endometrial changes that reduce the likelihood of pregnancy.
Indications / reported uses
  • Contraception in combination with ethinyl estradiol in authorised combined oral contraceptive products.

Sources: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/018206s022lbl.pdf · https://pubchem.ncbi.nlm.nih.gov/compound/Norgestrel · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Norgestrel PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Norgestrel Permitted Daily Exposure (PDE) report (the Norgestrel PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Norgestrel Occupational Exposure Limit (OEL) report (the Norgestrel OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.